| ATCC | American Type Culture Collection |
| CDC | Centers for Disease Control and Prevention |
| CHCA | Alpha-cyano-4-hydroxycinnamic acid |
| CIM | Carbapenem Inactivation Method |
| CLSI | Clinical and Laboratory Standards Institute |
| CRAB | Carbapenem-Resistant Acinetobacter baumannii |
| ECDC | European Centre for Disease Prevention and Control |
| ESBL | Extended-Spectrum Beta-Lactamases |
| ESKAPE | Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter spp. |
| EUCAST | European Committee on Antimicrobial Susceptibility Testing |
| FDA | Food and Drug Administration |
| GES | Guiana Extended-Spectrum β-Lactamase |
| IDSA | Infectious Diseases Society of America |
| IMP | Imipenemase |
| KORLD | National Reference Centre for Antimicrobial Susceptibility Testing |
| KPC | Klebsiella pneumoniae Carbapenemase |
| LPS | Lipopolysaccharide |
| MALDI-TOF MS | Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry |
| MBL | Metallo-β-Lactamase |
| MDR | Multidrug-Resistant |
| MIC | Minimum Inhibitory Concentration |
| NDM | New Delhi Metallo-β-Lactamase |
| NSBL | Narrow-Spectrum Beta-Lactamases |
| OMV | Outer Membrane Vesicles |
| OXA | Oxacillinases |
| PBP | Penicillin-Binding Proteins |
| PER | Pseudomonas Extended-Resistance β-Lactamase |
| PDR | Pandrug-Resistant |
| PSE | Pseudomonas-Specific Enzyme |
| RND | Resistance-Nodulation-Division |
| SIM | Seoul Imipenemase |
| VAP | Ventilator-Associated Pneumonia |
| VEB | Vietnamese Extended-Spectrum β-Lactamase |
| VIM | Verona Integron-Encoded Metallo-β-Lactamase |
| WHO | World Health Organization |
| XDR | Extensively Drug-Resistant |